Loading...
XSHE002326
Market cap1.04bUSD
Jan 14, Last price  
8.53CNY
1D
3.39%
1Q
-5.54%
Jan 2017
-41.39%
IPO
72.12%
Name

Zhejiang Yongtai Technology Co Ltd

Chart & Performance

D1W1MN
XSHE:002326 chart
P/E
—
P/S
1.85
EPS
—
Div Yield, %
3.15%
Shrs. gr., 5y
0.33%
Rev. gr., 5y
4.61%
Revenues
4.13b
-34.85%
260,680,541288,541,961393,072,284492,811,079511,034,881725,759,212838,874,861769,622,8071,061,449,3421,542,012,5791,748,536,2672,751,122,3063,295,273,7923,429,842,4323,450,306,5504,468,739,4446,336,219,3454,128,040,820
Net income
-620m
L
43,773,43341,149,06243,283,98657,242,92658,318,89063,709,36064,345,31819,848,26183,342,432144,265,024277,018,947182,236,146441,660,042271,699,33277,693,972280,285,674554,106,172-619,761,432
CFO
-329m
L
25,206,37615,126,03962,683,83268,107,4260099,803,86322,253,631166,637,10966,258,15184,232,45919,570,675719,671,411382,071,954345,147,877576,003,356223,682,226-329,126,584
Dividend
May 25, 20230.1 CNY/sh
Earnings
May 16, 2025

Profile

Zhejiang Yongtai Technology Co.,Ltd. engages in the research and development, manufacture, and sale of fluorinate chemicals in China. It offers fluorinated pharmaceutical compounds applied to drugs in fields, including anti-diabetic, anti-virus, cardiovascular, anti-bacterial quinolones, nervous system, etc.; and intermediates used in insecticides and fungicide. The company also provides liquid crystal material, lithium battery material, and other energy materials, as well as contract manufacturing service to pharmaceutical and chemical industry. Zhejiang Yongtai Technology Co.,Ltd. was founded in 1999 and is headquartered in Linhai, China.
URL
http://www.yongtaitech.com
IPO date
Dec 22, 2009
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
4,128,041
-34.85%
6,336,219
41.79%
Cost of revenue
4,414,764
4,998,702
Unusual Expense (Income)
NOPBT
(286,723)
1,337,518
NOPBT Margin
21.11%
Operating Taxes
(98,157)
138,962
Tax Rate
10.39%
NOPAT
(188,566)
1,198,556
Net income
(619,761)
-211.85%
554,106
97.69%
Dividends
(240,723)
(212,835)
Dividend yield
2.31%
1.11%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
2,652,444
2,561,791
Long-term debt
1,567,569
1,025,015
Deferred revenue
145,621
130,900
Other long-term liabilities
234,859
670,999
Net debt
2,780,210
2,313,128
Cash flow
Cash from operating activities
(329,127)
223,682
CAPEX
(671,871)
Cash from investing activities
(505,592)
Cash from financing activities
952,403
411,647
FCF
(430,359)
128,818
Balance
Cash
1,146,138
980,294
Long term investments
293,664
293,384
Excess cash
1,233,401
956,867
Stockholders' equity
2,789,339
3,252,389
Invested Capital
6,597,854
7,099,148
ROIC
18.18%
ROCE
16.57%
EV
Common stock shares outstanding
898,205
876,566
Price
11.62
-46.77%
21.83
-57.37%
Market cap
10,437,142
-45.46%
19,135,442
-57.37%
EV
13,743,268
22,043,743
EBITDA
120,266
1,699,185
EV/EBITDA
114.27
12.97
Interest
168,036
131,907
Interest/NOPBT
9.86%